On Thursday, Axcelis Technologies Inc (NASDAQ:ACLS)’s shares inclined 0.64% to $3.14.
Axcelis Technologies, Inc. (ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, declared that it has received a multi system, follow on order for the Purion XE™ high energy implanter from a major chipmaker in the Asia Pacific Region. The systems will be used to support a capacity expansion for 3D NAND Flash devices. The systems are scheduled to ship in the third quarter.
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips worldwide. It provides offers a line of high energy, high current, and medium current implanters for all application requirements. The company also provides dry strip systems for smaller wafers. In addition, it offers extensive aftermarket lifecycle products and services, counting used tools, spare parts, equipment upgrades, maintenance services, and customer training. The company sells its equipment and services to semiconductor chip manufacturers through direct sales force. Axcelis Technologies, Inc. was founded in 1995 and is headquartered in Beverly, Massachusetts.
Canadian Solar Inc. (NASDAQ:CSIQ)’s shares dropped -0.68% to $32.14.
Canadian Solar Inc. (CSIQ) one of the world’s largest solar power companies, recently declared that it served as the supplier of photovoltaic (PV) modules for the 42.9 MW Takataya Hibiki PV plant in Kitakyushu, Japan. In total, Canadian Solar offered 168,240 Canadian Solar CS6P-255P solar panels.
The Takataya Hibiki solar power plant, located in the Fukuoka prefecture, is predictable to reach commercial operation in August of 2015. While the independent power producer is Takataya Co. Ltd, JGC Corporation offered turnkey engineering, procurement, and construction services. Takataya Hibiki is predictable to generate 49 million kWh annually, which is equivalent to powering 13,600 homes. Furthermore, the system will displace about 32,340 metric tons of carbon dioxide every year.
Canadian Solar Inc., together with its auxiliaries, designs, develops, manufactures, and sells solar wafers, cells, and solar power products worldwide. The company operates in two segments, Module and Energy. Its products comprise various solar modules that are used in residential, commercial, and industrial solar power generation systems. The company also provides specialty solar products comprising of Andes Solar Home System, an off-grid solar system, designed to provide an economical source of electricity to homes and communities without access to grid; and Maple Solar System, a clean energy solution for families, in addition to solar system kits, which are a ready-to-install packages, such as inverters, racking system, and other accessories.
At the end of Thursday’s trade, Hasbro, Inc. (NASDAQ:HAS)‘s shares surged 0.10% to $78.42.
Hasbro, Inc. (HAS) declared that it will webcast its second quarter 2015 earnings conference call on Monday, July 20, 2015 at 8:30 a.m. Eastern Time, following the release of Hasbro’s financial results.
Hasbro, Inc., together with its auxiliaries, provides children’s and family leisure time products and services worldwide. The company’s product offerings comprise various toys comprising boys action figures, vehicles and playsets, girls toys, electronic toys and games, plush products, preschool toys and infant products, electronic interactive products, creative play, and toy-related specialty products. \
Corcept Therapeutics Incorporated (NASDAQ:CORT), ended its Thursday’s trading session with -1.39% loss, and closed at $6.39.
Corcept Therapeutics Incorporated (CORT) a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, oncologic and psychiatric disorders, declared recently that Daniel N. Swisher, Jr. has been designated to the company’s Board of Directors.
Mr. Swisher’s career in the biotechnology and pharmaceutical industry spans more than 25 years. He has been the Chief Executive Officer and a Board member of Sunesis Pharmaceuticals, Inc., a clinical-stage oncology company, since 2003. Mr. Swisher joined Sunesis in 2001 and served as its Chief Business Officer and Chief Financial Officer before becoming CEO. Before that, Mr. Swisher held a broad range of senior administration roles, counting Senior Vice President of Sales and Marketing at ALZA Corporation from 1992 to 2001. Since 2013, he has also served as Chairman of the Board of Cerus Corporation, a biopharmaceutical company.
Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of metabolic, oncologic, and psychiatric disorders in the United States. The company focuses on disorders that are associated with a steroid hormone called cortisol. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing’s syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
